Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 4
2008 3
2009 1
2010 1
2011 2
2012 1
2014 3
2015 2
2017 2
2018 2
2019 4
2020 7
2021 9
2022 5
2023 8
2024 12
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe.
Ammar D, Sanges C, Henderson D, Schapitz I, Hudecek M, Luu M, Schüssler-Lenz M, Buchholz C, Franz P, Reiche K, Köhl U, Ifrah N, Quesnel B, Thermeli M, Kersten MJ, Locatelli F, D'Amore ML, Bonini C, Casucci M, Philippar U, Doeswijk R, Thielen F, Uyl-de Groot C, Theelen J, Schröder B, Kremer A, Quaranta M, Prosper F, Van den Brulle J, Grawunder U, Donnadieu E, Galy A, Ferrand C, Worel N, Busch D, Briones J, Sellner L, Kuball J, Sureda A, Awigena-Cook J. Ammar D, et al. Among authors: reiche k. Cytotherapy. 2025 Sep 23:101984. doi: 10.1016/j.jcyt.2025.09.007. Online ahead of print. Cytotherapy. 2025. PMID: 41217312
ROR2-specific CAR T cells are effective against hematologic and solid tumors and well tolerated in mice.
Weber J, Rade M, Michael J, Tony LT, Freitag F, Spieler P, Müller C, Kalogirou C, Mainz L, Lehmann J, Klopfleisch R, Rosenfeldt MT, Danhof S, Kortüm KM, Köhl U, Einsele H, Rader C, Reiche K, Nerreter T, Hudecek M. Weber J, et al. Among authors: reiche k. Cell Rep Med. 2025 Oct 21;6(10):102400. doi: 10.1016/j.xcrm.2025.102400. Epub 2025 Oct 6. Cell Rep Med. 2025. PMID: 41056951 Free article.
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies.
Mazein A, Lopata O, Reiche K, Sewald K, Alb M, Sakellariou C, Gogesch P, Morgan H, Neuhaus V, Pham NN, Sommer C, Perkins E, Fogal B, Shoaib M, Schneider R, Satagopam V, Ostaszewski M. Mazein A, et al. Among authors: reiche k. Front Immunol. 2025 Aug 8;16:1601670. doi: 10.3389/fimmu.2025.1601670. eCollection 2025. Front Immunol. 2025. PMID: 40861455 Free PMC article.
Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies.
Weirauch U, Kreuz M, Birkenbihl C, Alb M, Quaranta M, Calzone L, Orozco-Ruiz S, Binder S, Fischer L, Clavreul S, Maguri M, Ferle M, Rade M, Azarias G, Hydren JR, Jamarik J, Schwarz D, Sebestyen Z, Kuball J, Popp G, Antoine C, Knockaert M, Schoeder CT, Fandrei D, Sanges C, Radvilas V, Gagelmann N, Rückert M, Penack O, Fricke S, Schmidt A, Ward C, Steinbeisser C, Van Gyseghem JM, Niarakis A, Garderet L, Hudecek M, Neumuth T, Platzbecker U, Köhl U, Demlova R, Kremer A, Franke S, Fröhlich H, Merz M, Reiche K; CERTAINTY Consortium. Weirauch U, et al. Among authors: reiche k. NPJ Digit Med. 2025 Aug 1;8(1):493. doi: 10.1038/s41746-025-01809-6. NPJ Digit Med. 2025. PMID: 40750653 Free PMC article. Review.
Prognostic Implications of Splenomegaly in BCMA-Directed CAR T-Cell Therapy for Relapsed Myeloma.
Wiemers TC, Ferle M, Ader J, Sotikova V, Fandrei D, Grieb N, Fischer L, Born P, Weidner H, Wang SY, Jentzsch M, Franke GN, Herling C, Metzeler K, Herling M, Heyn S, Denecke T, Reiche K, Platzbecker U, Vucinic V, Neumuth T, Meyer HJ, Merz M. Wiemers TC, et al. Among authors: reiche k. Transplant Cell Ther. 2025 Oct;31(10):789-803. doi: 10.1016/j.jtct.2025.07.003. Epub 2025 Jul 16. Transplant Cell Ther. 2025. PMID: 40680848 Free article.
Virtual twins for personalised CAR T-cell therapy in myeloma.
Reiche K, Weirauch U, Kreuz M, Fischer L, Gras L, Neumuth T, Platzbecker U, Köhl U, Demlova R, Kremer A, Fröhlich H, Franke S, Merz M; CERTAINTY Consortium. Reiche K, et al. Lancet Haematol. 2025 Jul;12(7):e490-e491. doi: 10.1016/S2352-3026(25)00170-X. Lancet Haematol. 2025. PMID: 40610172 No abstract available.
Predicting progression events in multiple myeloma from routine blood work.
Ferle M, Grieb N, Kreuz M, Ader J, Goldschmidt H, Mai EK, Bertsch U, Platzbecker U, Neumuth T, Reiche K, Oeser A, Merz M. Ferle M, et al. Among authors: reiche k. NPJ Digit Med. 2025 Apr 30;8(1):231. doi: 10.1038/s41746-025-01636-9. NPJ Digit Med. 2025. PMID: 40307417 Free PMC article.
Emerging T-cell lymphomas after CAR T-cell therapy.
Braun T, Kuschel F, Reiche K, Merz M, Herling M. Braun T, et al. Among authors: reiche k. Leukemia. 2025 Jun;39(6):1337-1341. doi: 10.1038/s41375-025-02574-x. Epub 2025 Apr 7. Leukemia. 2025. PMID: 40195525 Free PMC article. Review. No abstract available.
73 results